77 related articles for article (PubMed ID: 20619429)
21. An invariant surface patch on the TRIM5alpha PRYSPRY domain is required for retroviral restriction but dispensable for capsid binding.
Sebastian S; Grütter C; Strambio de Castillia C; Pertel T; Olivari S; Grütter MG; Luban J
J Virol; 2009 Apr; 83(7):3365-73. PubMed ID: 19153241
[TBL] [Abstract][Full Text] [Related]
22. TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.
Imam S; Talley S; Nelson RS; Dharan A; O'Connor C; Hope TJ; Campbell EM
J Virol; 2016 Jan; 90(7):3400-10. PubMed ID: 26764007
[TBL] [Abstract][Full Text] [Related]
23. Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner.
Sebastian S; Sokolskaja E; Luban J
J Virol; 2006 Feb; 80(4):2051-4. PubMed ID: 16439561
[TBL] [Abstract][Full Text] [Related]
24. Dynamics and restriction of murine leukemia virus cores in mitotic and interphase cells.
Elis E; Ehrlich M; Bacharach E
Retrovirology; 2015 Nov; 12():95. PubMed ID: 26577111
[TBL] [Abstract][Full Text] [Related]
25. Restriction of multiple divergent retroviruses by Lv1 and Ref1.
Hatziioannou T; Cowan S; Goff SP; Bieniasz PD; Towers GJ
EMBO J; 2003 Feb; 22(3):385-94. PubMed ID: 12554640
[TBL] [Abstract][Full Text] [Related]
26. Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells.
Sakuma R; Mael AA; Ikeda Y
J Virol; 2007 Sep; 81(18):10201-6. PubMed ID: 17609277
[TBL] [Abstract][Full Text] [Related]
27. Association of TRIMCyp and TRIM5α from assam macaques leads to a functional trade-off between HIV-1 and N-MLV inhibition.
Mu D; Zhu JW; Liu FL; Zheng HY; Zheng YT
Sci China Life Sci; 2018 Aug; 61(8):954-965. PubMed ID: 29705873
[TBL] [Abstract][Full Text] [Related]
28. Selection for loss of Ref1 activity in human cells releases human immunodeficiency virus type 1 from cyclophilin A dependence during infection.
Sayah DM; Luban J
J Virol; 2004 Nov; 78(21):12066-70. PubMed ID: 15479848
[TBL] [Abstract][Full Text] [Related]
29. A comparison of murine leukemia viruses that escape from human and rhesus macaque TRIM5αs.
Ohkura S; Stoye JP
J Virol; 2013 Jun; 87(11):6455-68. PubMed ID: 23536686
[TBL] [Abstract][Full Text] [Related]
30. Late domain-dependent inhibition of equine infectious anemia virus budding.
Shehu-Xhilaga M; Ablan S; Demirov DG; Chen C; Montelaro RC; Freed EO
J Virol; 2004 Jan; 78(2):724-32. PubMed ID: 14694104
[TBL] [Abstract][Full Text] [Related]
31. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
Ji S; Na L; Ren H; Wang Y; Wang X
J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
[TBL] [Abstract][Full Text] [Related]
32. Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the TRIM5alpha B-box 2 domain.
Diaz-Griffero F; Kar A; Perron M; Xiang SH; Javanbakht H; Li X; Sodroski J
J Virol; 2007 Oct; 81(19):10362-78. PubMed ID: 17626085
[TBL] [Abstract][Full Text] [Related]
33. Unique spectrum of activity of prosimian TRIM5alpha against exogenous and endogenous retroviruses.
Rahm N; Yap M; Snoeck J; Zoete V; Muñoz M; Radespiel U; Zimmermann E; Michielin O; Stoye JP; Ciuffi A; Telenti A
J Virol; 2011 May; 85(9):4173-83. PubMed ID: 21345948
[TBL] [Abstract][Full Text] [Related]
34. TRIM5alpha and TRIMCyp form apparent hexamers and their multimeric state is not affected by exposure to restriction-sensitive viruses or by treatment with pharmacological inhibitors.
Nepveu-Traversy ME; Bérubé J; Berthoux L
Retrovirology; 2009 Nov; 6():100. PubMed ID: 19886997
[TBL] [Abstract][Full Text] [Related]
35. Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins.
Ahi YS; Zhang S; Thappeta Y; Denman A; Feizpour A; Gummuluru S; Reinhard B; Muriaux D; Fivash MJ; Rein A
mBio; 2016 Nov; 7(6):. PubMed ID: 27879338
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of infectious murine leukemia virus production by Fv-4 env gene products exerting dominant negative effect on viral envelope glycoprotein.
Takeda A; Matano T
Microbes Infect; 2007; 9(14-15):1590-6. PubMed ID: 18023391
[TBL] [Abstract][Full Text] [Related]
37. Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1.
Stremlau M; Song B; Javanbakht H; Perron M; Sodroski J
Virology; 2006 Jul; 351(1):112-20. PubMed ID: 16643975
[TBL] [Abstract][Full Text] [Related]
38. Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV).
Meier K; Jaguva Vasudevan AA; Zhang Z; Bähr A; Kochs G; Häussinger D; Münk C
Virology; 2018 Oct; 523():52-63. PubMed ID: 30081309
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of human TRIM5alpha on HIV-1 production.
Zhang X; Kondo M; Chen J; Miyoshi H; Suzuki H; Ohashi T; Shida H
Microbes Infect; 2010 Sep; 12(10):768-77. PubMed ID: 20493962
[TBL] [Abstract][Full Text] [Related]
40. Reduction of N-tropic mutant porcine endogenous retrovirus infectivity by human tripartite motif-containing 5-isoform alpha.
Lee J; Cho YD; Heo YK; Kwon Y; Kim DG; Choi BS; Kim SS; Kim YB
Transplant Proc; 2011 Sep; 43(7):2774-8. PubMed ID: 21911161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
